← Insider buys
NGM

Ngm Biopharmaceuticals Inc

Column Group L P bought $428K of Ngm Biopharmaceuticals Inc

Director and 10% owner

Bought$427,891
$2.63Price
162,531Shares
+1%Stake

What NGM did for a copier

Prices for NGM after this filing aren't in yet.

Column Group L P's record

5 other buys with 3 months of prices since 2016: on average −28.4% against the S&P 500, and 0 of 5 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Fri, May 13. Filed Tue, May 17. Not investment advice.